Predicted to enable serine-type endopeptidase inhibitor activity. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); leukemia (multiple); and thrombophilia (multiple). Is an ortholog of human TFPI (tissue factor pathway inhibitor) and TFPI2 (tissue factor pathway inhibitor 2).
Map position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC.